Tuberculosis problems in the Asia-Pacific region

Respirology

Volumn 6, Issue 1, 2001, Pages 75-78

  Shimouchi, Akira ^a  

^a RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

Author keywords

Asia Pacific region; Directly observed treatment; Drug resistance; Short course (DOTS); Tuberculosis; Tuberculosis HIV co infection

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ASIA; COMORBIDITY; CONFERENCE PAPER; ENDEMIC DISEASE; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION CONTROL; PACIFIC ISLANDS; PRIORITY JOURNAL; SUPERINFECTION; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; ASIA; COMMUNICABLE DISEASE CONTROL; HEALTH PLAN IMPLEMENTATION; HIV INFECTIONS; HUMANS; NEW ZEALAND; PACIFIC ISLANDS; PATIENT COMPLIANCE; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0035027085     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1843.2001.00301.x     Document Type: Conference Paper

References (21)

1. Estimating causes of death: New methods and global and regional applications in 1990
2. Global Tuberculosis Control WHO Report
3. Tuberculosis in the urban poor settlement in the Philippines
4. Results of directly observed short-course chemotherapy in 112,842 Chinese patients with smear-positive tuberculosis
5. Drug resistance patterns of tuberculosis in Taiwan
6. Tuberculosis patients and practitioners in private clinics in India
7. Improving tuberculosis service in Chiang Rai Province: The challenge to control the dual epidemic of TB and HIV
8. Prevalence of drug-resistant tuberculosis in an area with Human Immunodeficiency Virus epidemics in northern Thailand